2025. Functional and Anatomical Outcomes Following Intravitreal Bevacizumab in Treatment-Naïve Centre-Involving Diabetic Macular Edema: A 3-Month Prospective Evaluation. Journal of Health and Rehabilitation Sciences. 4, 2 (Oct. 2025), 1–10. DOI:https://doi.org/10.33700/jhrs.4.2.172.